Navigation Links
New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
Date:9/4/2007

combination with fenofibrate in patients with mixed dyslipidemia (Fredrickson Type II B), and provided additional LDL-C reductions in these patients when added to a stable fenofibrate regimen. WelChol is not indicated for use in the treatment of mixed dyslipidemia or lipid parameters other than LDL-C.

For more information on WelChol, call 877-4-DSPROD (877-431-7763), or go to the WelChol web site at http://www.WelChol.com.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders.

For more information, please visit http://www.dsus.com.

Trademarks not owned by Daiichi Sankyo, Inc., are the property of their respective owners.

About the Survey

This survey was conducted by telephone within the United States by Harris Interactive on behalf of Daiichi Sankyo between January 17 and February 5, 2007 among a nationally representative sample of 400 U.S. adults ages 20 and older who have been diagnosed with high cholesterol and are doing something to manage it. Management includes: exercising regularly, changing diet, taking prescription medication, taking over-the-counter medication or eating cholesterol lowering food products. Figure
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Trace Analysis Optimizing Sensitivity Finnigan Surveyor PDA Detector
2. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
3. Economic survey reveals better 2006 results
4. Survey company sells Wisconsin GIS piece
5. MoneyTree Survey reports no venture investment activity in Wisconin in Q2
6. Madison top-ranked In Digital Cities Survey
7. Student survey shows surging demand for wireless access
8. Galactic survey reveals a new look for the Milky Way
9. Two Wisconsin companies hold spots on Computerworld employee survey
10. Money Tree survey shows lull in Wisconsin venture capital deals
11. Survey of High Tech Company Leaders Points Out Need for Personal Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
(Date:12/2/2009)... Corporation (Nasdaq: MATK ) announced today that it intends ... year 2009 on December 16, 2009, at approximately 4:00 p.m. ... ET Martek will conduct a conference call to discuss these ... the call live via webcast by visiting Martek,s web site ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... concept demonstration tires made with BioIsoprene technology, ... in the manufacture of synthetic rubber with renewable biomass, ... tire will be on display at a lounge in ... throughout December 21, while the other tire will make ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
... for Picoplatin -SOUTH SAN FRANCISCO, Calif., May 12 ... biopharmaceutical company focused on innovative oncology therapies, today announced ... present at the BIO International Convention on Tuesday, May ... Mr. Martell will provide an overview of the Company,s ...
... wide array of ACCU-CHEK programs centered around Behavior ... better self-care.INDIANAPOLIS, May 12 Roche, the maker ... pumps, announced today its long-term commitment to tackle ... Change through Patient Engagement (SM) program - a ...
... SEATTLE, May 12 Cell Therapeutics, Inc. ("CTI") (Nasdaq and ... Dutch Auction" tender offer (the "Exchange Offer") to exchange shares ... cash for an aggregate of $89.2 million principal amount for ... , ...
Other Biology Technology:Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 2Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 3Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes 2Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes 3Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 2Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 3Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 4Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 5Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 6
(Date:12/5/2009)... exhaustive research into venom produced by snakes and spiders, ... a mystery. Now, a study of 158 catfish species, ... Biology , has catalogued the presence of venom glands ... Wright, from the University of Michigan, USA, carried out ... techniques to elucidate the diversity and distribution of venomous ...
(Date:12/4/2009)... Royal Botanic Gardens, Kew and the Natural History Museum ... widespread than previously thought, with many commonly grown plants ... to being "meat eaters". A review paper, Murderous plants: ... is published today (4 December 2009) in the ...
(Date:12/3/2009)... WALL, N.J., Dec. 3 BIO-key International, Inc. ... public safety and finger-based biometric identification solutions, announced ... Special Shareholder Meeting held today approved the sale ... Mobile Systems Inc. Of the shares voted, 98.6% ...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Breast Feeding Benefits Moms and Babies 3A Report 60855 1Breast Feeding Benefits Moms and Babies 3A Report 60855 2New finding suggests prostate biopsy is not always necessary 60850 1New finding suggests prostate biopsy is not always necessary 60850 2New finding suggests prostate biopsy is not always necessary 60850 3Life Saving Estill Medical Technologies Receives Prestigious Dallas 100 28TM 29 Award 60846 1Life Saving Estill Medical Technologies Receives Prestigious Dallas 100 28TM 29 Award 60846 2
... of 2007, the assembly of the ESA,s Herschel far-infrared ... formation and evolution of stars and galaxies - will ... the media to a press conference in Friedrichshafen, Germany, ... spacecraft, its scientific objectives, and to view the very ...
... Pittsburgh of UPMC have discovered a unique population of adult ... to treat muscle injuries and diseases such as heart attack ... tissue, scientists in Children,s Stem Cell Research Center - led ... and characterized stem cells taken from blood vessels (known as ...
... Institutes of Health (NIH) has selected the first ... Genes, Environment and Health Initiative (GEI), a unique ... "This is ground-breaking research in understanding the complex ... Department of Health and Human Services Secretary Mike ...
Other Biology News:Pittsburgh scientists identify human source of stem cells with potential to repair muscle 2Pittsburgh scientists identify human source of stem cells with potential to repair muscle 3Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 2Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 3Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 4Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 5Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 6Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 7Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 8Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 9
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
... For use with suspension ... RiboCap™ uses vacuum filtration or ... culture media. Compatible with ... available in larger package sizes ...
GOAT ANTI SLI...
...
Biology Products: